ACNE WIPEOUT CLEAR PORE oil-FREE CLEANSER

Manufacturer
University Medical Pharmaceuticals Corp.
Effective date
2020-10-02
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:38:05

Label at a glance#

ProductACNE WIPEOUT CLEAR PORE oil-FREE CLEANSER
Active ingredientBENZOYL PEROXIDE
Label structure10 sections

Dosage and administration

Adults and children 12 years of age and older: Use every morning and evening. Apply to damp skin and gently massage, avoiding the eye area. Rinse well. If bothersome dryness or irritation occurs, reduce frequency of use.

Storage and handling

• store at room temperature (68° to 77° F) • Protect from freezing

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide 2.5% w/v

Purpose

OTC - PURPOSE SECTION

Acne treatment

Use

INDICATIONS & USAGE SECTION

 • For the treatment of acne

Warnings

WARNINGS SECTION

For external use only.

Do not use • If you are sensitive to Benzoyl Peroxide or have very sensitive skin. This product may cause irritation. Ask a doctor or pharmacist before use • If you are using other topical acne drugs at the same time or right after use of this product. This may increase dryness, redness or irritation of the skin. If this occurs, only one medication should be used unless a doctor directs otherwise.

When using this product • Avoid contact with eyes. If contact occurs, flush thoroughly with water. Keep away from lips and mouth. • Avoid unnecessary sun exposure and use a sunscreen. • Avoid product contact with hair and dyed fabrics, including towels, carpets and clothing which may be bleached by this product.

Stop use and ask a doctor if
• excessive irritation occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older:
Use every morning and evening. Apply to damp skin and gently massage, avoiding the eye area. Rinse well. If bothersome dryness or irritation occurs, reduce frequency of use.

Other information

STORAGE AND HANDLING SECTION

• store at room temperature (68° to 77° F)
• Protect from freezing

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Carbomer, Ethylhexylglycerin, Jojoba Esters, Phenoxyethanol, Sodium Hydroxide, Water, Silica, Sodium Dioctyl Sulfosuccinate, Xanthan Gum, 1,3 Propanediol, Dimethicone, PEG-40 Stearate.

OTC - QUESTIONS SECTION

Questions? call toll free 855-299-8800

SPL UNCLASSIFIED SECTION

DERMATOLOGICAL FIRST LINE ACNE CARE

GENTLE EXFOLIATING JOJOBA GEL

MICRONIZED 2.5% BENZOYL PEROXIDE ACNE WASH

with shine control

PART OF THE ACNE WIPEOUT CLINICAL ACNE SYSTEM

acnewipeout.com

made in usa

UNIVERSITY MEDICAL

PHARMACEUTICALS CORP

9671 Irvine Center Drive

Irvine, CA 92618

©2020

NOT TESTED ON ANIMALS

NON-COMEDOGENIC + FRAGRANCE FREE + PARABEN FREE + SULPHATE FREE

CLEANSE + KEEP SKIN

CALM + COMFORTABLE

Gently clears pores to deliver medication as you clean, controls shine, calms redness and leaves skin feeling soft and smooth.

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PackagingPackaging

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
845836benzoyl peroxide 2.5 % Medicated Liquid SoapPSN1
845836benzoyl peroxide 25 MG/ML Medicated Liquid SoapSCD1
845836benzoyl peroxide 2.5 % Medicated Liquid SoapSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d9d61457-6a5a-41fc-b418-e5479a2904b7Product name220230303
32012d5c-25ac-49c7-9d4c-1313177fff7cProduct name120230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
3f45980c-c196-47e5-0e5e-48b7c57327c5Product name520200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50544-151-002023-01-30C16284748780-1f386c649-e57f-0266-e053-dadaa90a7c1aACNE WIPEOUT™ CLEAR PORE OIL-FREE CLEANSER

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50544-151-00ACNE WIPEOUT CLEAR PORE oil-FREE CLEANSER120 mL in 1 TUBEGEL1201
50544-151-00ACNE WIPEOUT CLEAR PORE oil-FREE CLEANSER1 in 1 CARTONGEL11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50544-151ACNE WIPEOUT CLEAR PORE OIL-FREE CLEANSER (BENZOYL PEROXIDE) GEL [UNIVERSITY MEDICAL PHARMACEUTICALS CORP.]1Legacy NDC, 2 package rows20210213_1f87f7ec-c6da-45ed-8fc2-5af255ce782b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50544-15150544-151-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ee520c8a-78b9-4d72-a781-e2e493e51cdf1f87f7ec-c6da-45ed-8fc2-5af255ce782b2020-10-02WarningsExact identifier
spl id: ee520c8a-78b9-4d72-a781-e2e493e51cdf
spl set id: 1f87f7ec-c6da-45ed-8fc2-5af255ce782b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.